CDKN2A and lung adenocarcinoma: The homozygous deletion form of CDKN2A is common in patients with lung adenocarcinoma, with a prevalence of 22% in Chinese population; TCGA data of people of European descent shows a mutation frequency of 15%; whereas Korean data shows only a 4% prevalence of CDKN2A mutations (26).